GlaxoSmithKline Pharmaceuticals Limited Cash Flow Reinvestment Rate
GlaxoSmithKline Pharmaceuticals Limited cash flow reinvestment rate. GlaxoSmithKline Pharmaceuticals Limited (GLAXO) has a Cash Flow Reinvestment Rate of 0.00x as of December 2023, reinvesting Rs0.00 (capex Rs0.00 ) from operating cash flow of Rs342.20 Million. Explore GLAXO debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of GlaxoSmithKline Pharmaceuticals Limited (2005–2025)
Cash flow reinvestment rate of GlaxoSmithKline Pharmaceuticals Limited from 2005 to 2025. Historical reinvestment intensity for GlaxoSmithKline Pharmaceuticals Limited across 21 annual periods. Explore GLAXO capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
GlaxoSmithKline Pharmaceuticals Limited Cash Flow Reinvestment Rate by Year (2005–2025)
GlaxoSmithKline Pharmaceuticals Limited cash flow reinvestment rate by year from 2005 to 2025. Year-by-year capital reinvestment analysis for GlaxoSmithKline Pharmaceuticals Limited. For the full cash flow conversion analysis, see GlaxoSmithKline Pharmaceuticals Limited (GLAXO) cash conversion ratio.
| Year | Reinvestment Rate | Total Reinvested (INR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.05x | Rs688.30 Million | Rs12.90 Billion | Rs230.20 Million | ▼ -22.2% |
| 2024 | 0.07x | Rs399.33 Million | Rs5.82 Billion | Rs312.21 Million | ▼ -96.1% |
| 2023 | 1.76x | Rs8.52 Billion | Rs4.84 Billion | Rs440.40 Million | ▼ -22.8% |
| 2022 | 2.28x | Rs18.47 Billion | Rs8.11 Billion | Rs346.41 Million | ▲ +389.0% |
| 2021 | 0.47x | Rs2.69 Billion | Rs5.78 Billion | Rs442.27 Million | ▼ -7.8% |
| 2020 | 0.51x | Rs2.48 Billion | Rs4.90 Billion | Rs1.56 Billion | ▼ -35.2% |
| 2019 | 0.78x | Rs3.11 Billion | Rs3.99 Billion | Rs2.91 Billion | ▼ -49.9% |
| 2018 | 1.56x | Rs7.36 Billion | Rs4.73 Billion | Rs4.03 Billion | ▼ -52.7% |
| 2017 | 3.29x | Rs7.76 Billion | Rs2.36 Billion | Rs3.04 Billion | ▼ -42.7% |
| 2016 | 5.74x | Rs7.99 Billion | Rs1.39 Billion | Rs2.32 Billion | ▲ +494.3% |
| 2015 | 0.97x | Rs2.61 Billion | Rs2.70 Billion | Rs1.30 Billion | ▲ +160.0% |
| 2014 | 0.37x | Rs1.05 Billion | Rs2.81 Billion | Rs582.22 Million | ▲ +198.2% |
| 2013 | 0.12x | Rs390.76 Million | Rs3.14 Billion | Rs390.76 Million | ▼ -0.6% |
| 2012 | 0.13x | Rs420.95 Million | Rs3.36 Billion | Rs420.95 Million | ▲ +181.0% |
| 2011 | 0.04x | Rs213.94 Million | Rs4.79 Billion | Rs213.94 Million | ▼ -24.8% |
| 2010 | 0.06x | Rs303.67 Million | Rs5.12 Billion | Rs303.67 Million | ▼ -17.9% |
| 2009 | 0.07x | Rs238.79 Million | Rs3.30 Billion | Rs238.79 Million | ▲ +50.5% |
| 2008 | 0.05x | Rs153.26 Million | Rs3.19 Billion | Rs153.26 Million | ▼ -33.3% |
| 2007 | 0.07x | Rs186.23 Million | Rs2.59 Billion | Rs186.23 Million | ▲ +7.6% |
| 2006 | 0.07x | Rs233.91 Million | Rs3.49 Billion | Rs233.91 Million | ▲ +63.6% |
| 2005 | 0.04x | Rs93.72 Million | Rs2.29 Billion | Rs93.72 Million | — |